Roche's Xolair reduces reactions to severe food allergies in study
(Source: Reuters: Health)
Source: Reuters: Health - February 25, 2024 Category: Consumer Health News Source Type: news
What to Know About Xolair and Food Allergies
The drug does not completely prevent reactions, but it can reduce the risks posed by trace amounts of food allergens. (Source: NYT Health)
Source: NYT Health - February 25, 2024 Category: Consumer Health News Authors: Roni Caryn Rabin Tags: your-feed-science Allergies Food Children and Childhood Drugs (Pharmaceuticals) Immune System Clinical Trials Research Health Insurance and Managed Care Source Type: news
Drug Drastically Reduces Children ’s Reactions to Traces of Food Allergens
Xolair cuts the risk of dangerous reactions after exposure to minute amounts of allergens, researchers reported. But children taking it still must avoid risky foods. (Source: NYT Health)
Source: NYT Health - February 25, 2024 Category: Consumer Health News Authors: Roni Caryn Rabin Tags: your-feed-science Allergies Food Peanuts Children and Childhood Research Drugs (Pharmaceuticals) Immune System Eggs Milk Clinical Trials American Academy of Allergy Asthma and Immunology New England Journal of Medicine Genentech Source Type: news
Asthma drug limits serious reactions to allergy-triggering foods, study says
A drug approved to treat allergic asthma and chronic hives can limit children ' s dangerous allergic responses to small amounts of allergy-triggering foods, a new study reveals. (Source: Health News - UPI.com)
Source: Health News - UPI.com - February 25, 2024 Category: Consumer Health News Source Type: news
An Asthma Drug Can Drastically Reduce Food Allergies
About 20 million people in the U.S.—including four million children—have food allergies. Now, there’s a new way to reduce their risk of severe allergic reactions. A study published in the New England Journal of Medicine reports that the drug omalizumab, or Xolair, allows people with food allergies to tolerate higher doses of allergenic foods before developing a reaction after an accidental exposure. It also leads to milder reactions if they are exposed.
[time-brightcove not-tgx=”true”]
The drug was originally approved more than two decades ago to treat allergic asthma. But because of this ...
Source: TIME: Health - February 25, 2024 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthscienceclimate Source Type: news
Omalizumab Limits Dangerous Reactions To Allergy Triggering Food
Study finds a drug that binds to allergy-causing antibodies can protect children from dangerous reactions to accidentally eating allergy-triggering foods (Source: Disabled World)
Source: Disabled World - February 25, 2024 Category: Disability Tags: Food Allergies Source Type: news
Benralizumab Matches Mepolizumab for Rare Vasculitis
(MedPage Today) -- WASHINGTON -- Treatment with benralizumab (Fasenra) was noninferior to mepolizumab (Nucala) for relapsing or refractory eosinophilic granulomatosis with polyangiitis (EGPA), the randomized MANDARA trial showed.
Among 140 patients... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - February 24, 2024 Category: Allergy & Immunology Source Type: news
Antibody reduces allergic reactions to multiple foods in NIH clinical trial
Drug can help protect kids with multiple food allergies during accidental exposure. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - February 23, 2024 Category: American Health Source Type: news
Infographic: Medical Blogs That Grab Doctors' Attention Infographic: Medical Blogs That Grab Doctors' Attention
Several of the interesting medical blogs that have caught physicians ' eyes, on topics from injury prevention to the life of a medical student, are highlighted.Medscape (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - February 23, 2024 Category: Allergy & Immunology Tags: Family Medicine/Primary Care Article Source Type: news
Europe Greenlights Two Avian Flu Vaccines Europe Greenlights Two Avian Flu Vaccines
The vaccines, Celldemic and Incellipan, protect against the H5N1 subtype of the influenza A virus.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - February 23, 2024 Category: Allergy & Immunology Tags: Infectious Diseases Source Type: news
Travere Drug for Rare Kidney Condition Recommended for EU Approval Travere Drug for Rare Kidney Condition Recommended for EU Approval
Vifor Pharma and partner Travere Therapeutics on Friday won an endorsement for approval from the European Union ' s drug regulator for their drug Filspari, part of an industry...Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - February 23, 2024 Category: Allergy & Immunology Tags: Nephrology Source Type: news
Diagnosing Infection in Tocilizumab Users: What's Helpful? Diagnosing Infection in Tocilizumab Users: What's Helpful?
Area under the curve for routine biomarkers distinguished infected and noninfected adults with inflammatory diseases.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - February 23, 2024 Category: Allergy & Immunology Tags: Rheumatology Source Type: news
NY AG Urges Stricter Asthma Drug Warnings Due to Children ’s Mental Health Risks
The A.G., Letitia James, called on the F.D.A. to redouble efforts to alert doctors about potential side effects of Singulair and to consider discouraging use of the drug for children. (Source: NYT Health)
Source: NYT Health - February 22, 2024 Category: Consumer Health News Authors: Christina Jewett and Benjamin Mueller Tags: Children and Childhood Attorneys General Asthma Drugs (Pharmaceuticals) Allergies Food and Drug Administration New York Times James, Letitia your-feed-healthcare Source Type: news
' Deep Phenotyping' Identifies Abnormalities in ME/CFS'Deep Phenotyping' Identifies Abnormalities in ME/CFS
New research from the National Institutes of Health identified " clear objective changes " in people with postinfectious myalgic encephalomyelitis/chronic fatigue syndrome.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - February 22, 2024 Category: Allergy & Immunology Tags: Rheumatology Source Type: news
Dupilumab for EoE: How Is it Improving Treatment? Dupilumab for EoE: How Is it Improving Treatment?
The drug was a boon for many patients, mainly those with moderate to severe disease, but cost and insurance approvals posed challenges.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - February 21, 2024 Category: Allergy & Immunology Tags: Gastroenterology Source Type: news
